EMA Authorised: Gencebok (Caffeine citrate) — Gennisium Pharma

View source ↗

Summary

EMA authorised Gencebok, a caffeine citrate medicine by Gennisium Pharma, for the treatment of apnea (apnea of prematurity).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity

Drugs mentioned

• Gencebok (Caffeine citrate)

Snippet

Status: Authorised. Therapeutic area: Apnea. MAH: Gennisium Pharma. Decision date: 07/03/2025